Search

everythinglearnresearchcommunity

for

Search:↓

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Inhibiting TYK2 can restore hair growth in alopecia areata.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Researchers made new compounds that could potentially be developed into anticancer drugs.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Genetic testing is crucial before giving azathioprine to avoid severe side effects.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Methimazole can cause severe low platelet count in Graves' disease patients, so monitoring and alternative treatments are important.

Minoxidil helps restore thymus size in 22q11.2 deletion syndrome.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

A new compound shows promise as a topical treatment for hair loss.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Thyroid receptor agonists may treat male pattern baldness without harmful side effects.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.

Vitamin D3 analogs can promote hair growth in mice genetically prone to hair loss.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.